Glenmark Ranitidine Tablets USP 150 mg recall: Nitrosamine Impurity
Glenmark Ranitidine Tablets USP 150 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India…
Why was Glenmark Ranitidine Tablets USP 150 mg recalled?
CGMP Deviations: Presence of NDMA impurity detected in product.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
7701033A 7701826A 7702344A 7702345A 7702489A 7702706A 7702707A 7702708A 7702858A 7702859A 7702860A 7702928A 7702929A 7703196A 7703634A 7704492A 7704493A 7705159A 19190289 19190342 19190372
- Product
- Glenmark Ranitidine Tablets USP 150 mg Rx Only 100 Tablets Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bandez, Goa 403513, India…
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA
- Quantity
- 217,956 bottles
- Distribution
- Natiowide
- Recall date
- January 15, 2020
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)